|
TOPLINE STORIES:
Discover the Roll Back Malaria Zambezi Expedition
 On 29th March 2008, the Roll Back Malaria Zambezi Expedition launches into a two months voyage to showcase successes and highlight challenges associated with the fight against one of the globe's leading infectious killers. This unparalleled endeavor is made possible thanks to the six malaria endemic countries in the Zambezi region and a public private partnership effort. Visit the dedicated Zambezi Expedition website today to learn more.
View RBM Press Release [in English] [en français]
Visit Zambezi Expedition website
Distinguished Prize for Malaria
 Tokyo, Japan, 26 March 2008 - The Government of Japan announced today its decision to award the inaugural Hideyo Noguchi Africa Prizes to Brian Greenwood, Professor of Clinical Tropical Medicine, London School of Hygiene and Tropical Medicine, UK, for his bold and innovative work on malaria and Miriam K. Were, co-founder and Health Specialist UZIMA Foundation, Kenya.
View the Press release
|
The Gates Foundation Grants 200 million To Malaria Research and Control Programs
 The Bill & Melinda Gates Foundation recently awarded 13 new grants, totaling almost US $200 million, to help fight malaria. This new funding adds to the Foundation's existing portfolio of grants that support initiatives to strengthen existing malaria control programmes and to pursue a wide range of research on new strategies to prevent and treat the disease. Among these new grants:
- $42 million to the London School of Hygiene and Tropical Medicine to identify ways to optimize delivery of artemisinin combination therapy
- $37 million to the Medicines for Malaria Venture to accelerate the development of effective, affordable malaria drugs
- $30 million to the Liverpool School of Tropical Medicine to improve the control and treatment of malaria in pregnancy in Africa, Asia and Latin America
- $15 million to PATH for additional support to the Malaria Control and Evaluation Program in Africa (MACEPA)
- $9 million to the Seattle Biomedical Research Institute for research on a malaria vaccine for pregnant women
- $3 million to The Special Programme for Research and Training in Tropical Diseases (TDR) to study ways to prevent resistance to artemisinin
More information
|
|
RECENT EVENTS:
RBM applauds US decision to step up funding against malaria
 Washington DC, 13 March 2008 - The Roll Back Malaria Partnership Secretariat welcomes the US Senate Foreign Relations Committee approval of the "Tom Lantos and Henry J. Hyde Global Leadership on HIV/ AIDS, Tuberculosis and Malaria Reauthorization Act of 2008". The USD 50bn in approved spending is expected to include USD 5bn to fight malaria between 2009 and 2013 via bilateral programs and the Global Fund. The US funding will address the challenges of tackling malaria in high-burden areas, and allow improvements in program monitoring and evaluation.
View US Senate bill S. 2731
Non-profit and Private Companies Unite to Develop a Low-Cost Life-Saving Ingredient in Malaria Treatment
 San Francisco, CA, Emeryville, CA & Paris, France, March 3, 2008 - The Institute for OneWorld Health (iOWH), a US-based nonprofit pharmaceutical company, together with synthetic biology innovator Amyris Biotechnologies, and leading pharmaceutical company Sanofi-aventis announced today that they have entered into an agreement for the development of semi-synthetic artemisinin, a key ingredient in first-line malaria treatments.
This collaboration aims to create a complementary source of non-seasonal, high-quality and affordable artemisinin to supplement the current botanical supply, thereby enabling millions of people infected with malaria to gain consistent access to lower-cost, life-saving artemisinin-based combination therapies (ACTs).
View iOWH Press Release
|
The Global Fund Opens its Eighth Funding Round
Last chance to request funding to reach 2010 Abuja targets
Geneva, March 3, 2008 - The Global Fund to Fight AIDS, Tuberculosis and Malaria today began accepting proposals for a new funding round. This year's Round 8 of proposals is the last chance for malaria-endemic countries in Africa to obtain funding for malaria control activities geared towards reaching the Abuja targets of halving the malaria burden in Africa by 2010.
The Roll Back Malaria (RBM) Partnership will provide targeted support to African countries to develop their malaria proposals for Round 8, resolve funding bottlenecks and accelerate the process of channeling funds to malaria control programmes.
RBM Partnership is focusing on the countries that are most affected by the disease to help them prepare comprehensive needs assessments and business plans for scaling-up malaria control interventions. Nigeria and the DRC are targeted for rapid assistance as they suffer half of the mortality burden in Africa and are in urgent need of funding.
View The Global Fund Press Release
More info on Round 8
Gates stimulates innovation in the fight against malaria and other infectious diseases
31 March 2008 - The Gates Foundation calls for proposals for the first round of Grand Challenges Explorations, a US$100 million initiative to help scientists pursue innovative ideas for solving major global health problems.
Grant proposals are being accepted online until May 30, 2008
|
